0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Preimplantation Genetic Diagnosis (PGD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-34S2823
Home | Market Reports | Health| Reproductive Health
Global Preimplantation Genetic Diagnosis PGD Market Insights Forecast to 2028
BUY CHAPTERS

Preimplantation Genetic Diagnosis (PGD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-34S2823
Report
October 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Preimplantation Genetic Diagnosis (PGD) - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Preimplantation Genetic Diagnosis (PGD) - Market

Preimplantation Genetic Diagnosis (PGD) - Market

The global market for Preimplantation Genetic Diagnosis (PGD) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Diagnosis (PGD), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Preimplantation Genetic Diagnosis (PGD) by region & country, by Type, and by Application.
The Preimplantation Genetic Diagnosis (PGD) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Diagnosis (PGD).
Market Segmentation

Scope of Preimplantation Genetic Diagnosis (PGD) - Market Report

Report Metric Details
Report Name Preimplantation Genetic Diagnosis (PGD) - Market
CAGR 5%
Segment by Type:
Segment by Application
  • Maternity Centers & Fertility Clinics
  • Hospitals, Diagnostic Labs, and Service Providers
  • Research Laboratories & Academic Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Coopersurgical, Abbott Laboratories, Natera, Takara Bio, Oxford Gene Technology, Yikon Genomics, Progenesis, Beijing Genomics Institute, Invitae, Invicta Genetics, Combimatrix, Genea Limited, Bioarray, Quest Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Preimplantation Genetic Diagnosis (PGD) manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Preimplantation Genetic Diagnosis (PGD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Preimplantation Genetic Diagnosis (PGD) in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Preimplantation Genetic Diagnosis (PGD) - Market report?

Ans: The main players in the Preimplantation Genetic Diagnosis (PGD) - Market are Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Coopersurgical, Abbott Laboratories, Natera, Takara Bio, Oxford Gene Technology, Yikon Genomics, Progenesis, Beijing Genomics Institute, Invitae, Invicta Genetics, Combimatrix, Genea Limited, Bioarray, Quest Diagnostics

What are the Application segmentation covered in the Preimplantation Genetic Diagnosis (PGD) - Market report?

Ans: The Applications covered in the Preimplantation Genetic Diagnosis (PGD) - Market report are Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic Institutes

What are the Type segmentation covered in the Preimplantation Genetic Diagnosis (PGD) - Market report?

Ans: The Types covered in the Preimplantation Genetic Diagnosis (PGD) - Market report are Chromosomal Abnormalities, Gender Selection, X-linked Diseases, Aneuploidy, Single Gene Disorders, Others

Recommended Reports

Genetic Testing Markets

Gene Therapy & Products

Disease Diagnostics Market

1 Market Overview
1.1 Preimplantation Genetic Diagnosis (PGD) Product Introduction
1.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast
1.3 Preimplantation Genetic Diagnosis (PGD) Market Trends & Drivers
1.3.1 Preimplantation Genetic Diagnosis (PGD) Industry Trends
1.3.2 Preimplantation Genetic Diagnosis (PGD) Market Drivers & Opportunity
1.3.3 Preimplantation Genetic Diagnosis (PGD) Market Challenges
1.3.4 Preimplantation Genetic Diagnosis (PGD) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preimplantation Genetic Diagnosis (PGD) Players Revenue Ranking (2023)
2.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue by Company (2019-2024)
2.3 Key Companies Preimplantation Genetic Diagnosis (PGD) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Preimplantation Genetic Diagnosis (PGD) Product Offered
2.5 Key Companies Time to Begin Mass Production of Preimplantation Genetic Diagnosis (PGD)
2.6 Preimplantation Genetic Diagnosis (PGD) Market Competitive Analysis
2.6.1 Preimplantation Genetic Diagnosis (PGD) Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Preimplantation Genetic Diagnosis (PGD) Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chromosomal Abnormalities
3.1.2 Gender Selection
3.1.3 X-linked Diseases
3.1.4 Aneuploidy
3.1.5 Single Gene Disorders
3.1.6 Others
3.2 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Type
3.2.1 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Preimplantation Genetic Diagnosis (PGD) Sales Value, by Type (2019-2030)
3.2.3 Global Preimplantation Genetic Diagnosis (PGD) Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Maternity Centers & Fertility Clinics
4.1.2 Hospitals, Diagnostic Labs, and Service Providers
4.1.3 Research Laboratories & Academic Institutes
4.2 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Application
4.2.1 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Preimplantation Genetic Diagnosis (PGD) Sales Value, by Application (2019-2030)
4.2.3 Global Preimplantation Genetic Diagnosis (PGD) Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region
5.1.1 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (2019-2024)
5.1.3 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (2025-2030)
5.1.4 Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
5.2.2 North America Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
5.3.2 Europe Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
5.4.2 Asia Pacific Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
5.5.2 South America Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
5.6.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preimplantation Genetic Diagnosis (PGD) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Preimplantation Genetic Diagnosis (PGD) Sales Value
6.3 United States
6.3.1 United States Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.3.2 United States Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.4.2 Europe Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.5.2 China Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.6.2 Japan Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.7.2 South Korea Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.8.2 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019-2030
6.9.2 India Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Preimplantation Genetic Diagnosis (PGD) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Profile
7.1.2 Illumina Main Business
7.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.1.4 Illumina Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.1.5 Illumina Recent Developments
7.2 Thermo Fisher
7.2.1 Thermo Fisher Profile
7.2.2 Thermo Fisher Main Business
7.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.2.4 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.3.4 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.3.5 PerkinElmer Recent Developments
7.4 PerkinElmer
7.4.1 PerkinElmer Profile
7.4.2 PerkinElmer Main Business
7.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.4.4 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.4.5 PerkinElmer Recent Developments
7.5 Coopersurgical
7.5.1 Coopersurgical Profile
7.5.2 Coopersurgical Main Business
7.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.5.4 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.5.5 Coopersurgical Recent Developments
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Profile
7.6.2 Abbott Laboratories Main Business
7.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.6.4 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Laboratories Recent Developments
7.7 Natera
7.7.1 Natera Profile
7.7.2 Natera Main Business
7.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.7.4 Natera Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.7.5 Natera Recent Developments
7.8 Takara Bio
7.8.1 Takara Bio Profile
7.8.2 Takara Bio Main Business
7.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.8.4 Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.8.5 Takara Bio Recent Developments
7.9 Oxford Gene Technology
7.9.1 Oxford Gene Technology Profile
7.9.2 Oxford Gene Technology Main Business
7.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.9.4 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.9.5 Oxford Gene Technology Recent Developments
7.10 Yikon Genomics
7.10.1 Yikon Genomics Profile
7.10.2 Yikon Genomics Main Business
7.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.10.4 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.10.5 Yikon Genomics Recent Developments
7.11 Progenesis
7.11.1 Progenesis Profile
7.11.2 Progenesis Main Business
7.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.11.4 Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.11.5 Progenesis Recent Developments
7.12 Beijing Genomics Institute
7.12.1 Beijing Genomics Institute Profile
7.12.2 Beijing Genomics Institute Main Business
7.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.12.4 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.12.5 Beijing Genomics Institute Recent Developments
7.13 Invitae
7.13.1 Invitae Profile
7.13.2 Invitae Main Business
7.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.13.4 Invitae Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.13.5 Invitae Recent Developments
7.14 Invicta Genetics
7.14.1 Invicta Genetics Profile
7.14.2 Invicta Genetics Main Business
7.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.14.4 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.14.5 Invicta Genetics Recent Developments
7.15 Combimatrix
7.15.1 Combimatrix Profile
7.15.2 Combimatrix Main Business
7.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.15.4 Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.15.5 Combimatrix Recent Developments
7.16 Genea Limited
7.16.1 Genea Limited Profile
7.16.2 Genea Limited Main Business
7.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.16.4 Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.16.5 Genea Limited Recent Developments
7.17 Bioarray
7.17.1 Bioarray Profile
7.17.2 Bioarray Main Business
7.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.17.4 Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.17.5 Bioarray Recent Developments
7.18 Quest Diagnostics
7.18.1 Quest Diagnostics Profile
7.18.2 Quest Diagnostics Main Business
7.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
7.18.4 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue (US$ Million) & (2019-2024)
7.18.5 Quest Diagnostics Recent Developments
8 Industry Chain Analysis
8.1 Preimplantation Genetic Diagnosis (PGD) Industrial Chain
8.2 Preimplantation Genetic Diagnosis (PGD) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Preimplantation Genetic Diagnosis (PGD) Sales Model
8.5.2 Sales Channel
8.5.3 Preimplantation Genetic Diagnosis (PGD) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Preimplantation Genetic Diagnosis (PGD) Market Trends
    Table 2. Preimplantation Genetic Diagnosis (PGD) Market Drivers & Opportunity
    Table 3. Preimplantation Genetic Diagnosis (PGD) Market Challenges
    Table 4. Preimplantation Genetic Diagnosis (PGD) Market Restraints
    Table 5. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Preimplantation Genetic Diagnosis (PGD) Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Preimplantation Genetic Diagnosis (PGD) Product Type
    Table 9. Key Companies Time to Begin Mass Production of Preimplantation Genetic Diagnosis (PGD)
    Table 10. Global Preimplantation Genetic Diagnosis (PGD) Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnosis (PGD) as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Preimplantation Genetic Diagnosis (PGD) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Preimplantation Genetic Diagnosis (PGD) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Preimplantation Genetic Diagnosis (PGD) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Preimplantation Genetic Diagnosis (PGD) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (2019-2024) & (%)
    Table 27. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Preimplantation Genetic Diagnosis (PGD) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Preimplantation Genetic Diagnosis (PGD) Sales Value, (2025-2030) & (US$ Million)
    Table 31. Illumina Basic Information List
    Table 32. Illumina Description and Business Overview
    Table 33. Illumina Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Illumina (2019-2024)
    Table 35. Illumina Recent Developments
    Table 36. Thermo Fisher Basic Information List
    Table 37. Thermo Fisher Description and Business Overview
    Table 38. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Thermo Fisher (2019-2024)
    Table 40. Thermo Fisher Recent Developments
    Table 41. Agilent Technologies Basic Information List
    Table 42. Agilent Technologies Description and Business Overview
    Table 43. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Agilent Technologies (2019-2024)
    Table 45. Agilent Technologies Recent Developments
    Table 46. PerkinElmer Basic Information List
    Table 47. PerkinElmer Description and Business Overview
    Table 48. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of PerkinElmer (2019-2024)
    Table 50. PerkinElmer Recent Developments
    Table 51. Coopersurgical Basic Information List
    Table 52. Coopersurgical Description and Business Overview
    Table 53. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Coopersurgical (2019-2024)
    Table 55. Coopersurgical Recent Developments
    Table 56. Abbott Laboratories Basic Information List
    Table 57. Abbott Laboratories Description and Business Overview
    Table 58. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Abbott Laboratories (2019-2024)
    Table 60. Abbott Laboratories Recent Developments
    Table 61. Natera Basic Information List
    Table 62. Natera Description and Business Overview
    Table 63. Natera Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Natera (2019-2024)
    Table 65. Natera Recent Developments
    Table 66. Takara Bio Basic Information List
    Table 67. Takara Bio Description and Business Overview
    Table 68. Takara Bio Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Takara Bio (2019-2024)
    Table 70. Takara Bio Recent Developments
    Table 71. Oxford Gene Technology Basic Information List
    Table 72. Oxford Gene Technology Description and Business Overview
    Table 73. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Oxford Gene Technology (2019-2024)
    Table 75. Oxford Gene Technology Recent Developments
    Table 76. Yikon Genomics Basic Information List
    Table 77. Yikon Genomics Description and Business Overview
    Table 78. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Yikon Genomics (2019-2024)
    Table 80. Yikon Genomics Recent Developments
    Table 81. Progenesis Basic Information List
    Table 82. Progenesis Description and Business Overview
    Table 83. Progenesis Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Progenesis (2019-2024)
    Table 85. Progenesis Recent Developments
    Table 86. Beijing Genomics Institute Basic Information List
    Table 87. Beijing Genomics Institute Description and Business Overview
    Table 88. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Beijing Genomics Institute (2019-2024)
    Table 90. Beijing Genomics Institute Recent Developments
    Table 91. Invitae Basic Information List
    Table 92. Invitae Description and Business Overview
    Table 93. Invitae Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Invitae (2019-2024)
    Table 95. Invitae Recent Developments
    Table 96. Invicta Genetics Basic Information List
    Table 97. Invicta Genetics Description and Business Overview
    Table 98. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Invicta Genetics (2019-2024)
    Table 100. Invicta Genetics Recent Developments
    Table 101. Combimatrix Basic Information List
    Table 102. Combimatrix Description and Business Overview
    Table 103. Combimatrix Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Combimatrix (2019-2024)
    Table 105. Combimatrix Recent Developments
    Table 106. Genea Limited Basic Information List
    Table 107. Genea Limited Description and Business Overview
    Table 108. Genea Limited Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Genea Limited (2019-2024)
    Table 110. Genea Limited Recent Developments
    Table 111. Bioarray Basic Information List
    Table 112. Bioarray Description and Business Overview
    Table 113. Bioarray Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Bioarray (2019-2024)
    Table 115. Bioarray Recent Developments
    Table 116. Quest Diagnostics Basic Information List
    Table 117. Quest Diagnostics Description and Business Overview
    Table 118. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Preimplantation Genetic Diagnosis (PGD) Business of Quest Diagnostics (2019-2024)
    Table 120. Quest Diagnostics Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Preimplantation Genetic Diagnosis (PGD) Downstream Customers
    Table 124. Preimplantation Genetic Diagnosis (PGD) Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Preimplantation Genetic Diagnosis (PGD) Product Picture
    Figure 2. Global Preimplantation Genetic Diagnosis (PGD) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Preimplantation Genetic Diagnosis (PGD) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Preimplantation Genetic Diagnosis (PGD) Report Years Considered
    Figure 5. Global Preimplantation Genetic Diagnosis (PGD) Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Preimplantation Genetic Diagnosis (PGD) Revenue in 2023
    Figure 7. Preimplantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chromosomal Abnormalities Picture
    Figure 9. Gender Selection Picture
    Figure 10. X-linked Diseases Picture
    Figure 11. Aneuploidy Picture
    Figure 12. Single Gene Disorders Picture
    Figure 13. Others Picture
    Figure 14. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Maternity Centers & Fertility Clinics
    Figure 17. Product Picture of Hospitals, Diagnostic Labs, and Service Providers
    Figure 18. Product Picture of Research Laboratories & Academic Institutes
    Figure 19. Global Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Preimplantation Genetic Diagnosis (PGD) Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Preimplantation Genetic Diagnosis (PGD) Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Preimplantation Genetic Diagnosis (PGD) Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Preimplantation Genetic Diagnosis (PGD) Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Preimplantation Genetic Diagnosis (PGD) Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Preimplantation Genetic Diagnosis (PGD) Sales Value (%), (2019-2030)
    Figure 32. United States Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Preimplantation Genetic Diagnosis (PGD) Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Preimplantation Genetic Diagnosis (PGD) Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Preimplantation Genetic Diagnosis (PGD) Sales Value by Application (%), 2023 VS 2030
    Figure 53. Preimplantation Genetic Diagnosis (PGD) Industrial Chain
    Figure 54. Preimplantation Genetic Diagnosis (PGD) Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS